SynthesisFrontiers in pharmacology2025

Efficacy and safety of IL-23 p19 inhibitors in the treatment for inflammatory bowel disease: a systematic review and meta-analysis.

Shuhan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.